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ABSTRACT Paediatric tuberculosis (TB) is a key indicator for recent transmission and presents a reservoir
for the disease. We describe trends in epidemiology, microbiological characteristics and treatment outcome
in Denmark between 2000 and 2009. Data were retrieved from the national TB surveillance system and the
International Reference Laboratory of Mycobacteriology.
In total, 323 TB cases were reported in children aged ,15 years, accounting for 7.6% of all notified cases
in Denmark. The overall incidence rate of childhood TB declined from 4.1 per 100 000 to 1.9 per 100 000 in
the study period. Immigrant children comprised 79.6% of all cases, with the highest incidence rate of 94.1
per 100 000 children in 2001. In contrast to immigrant children, the majority of Danish children were aged
,5 years and had a known exposure to TB. Pulmonary TB was the commonest presentation. Only half of
the cases were culture confirmed.
We observed an overall decreasing trend in the child to adult notification ratio, but a slight increase in the
ratio when calculated specifically for ethnic Danes.
Childhood TB needs continuous attention with a special focus on risk groups. Emphasis on improving
early TB case detection, contact tracing and further implementation of preventive treatment is necessary.
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Introduction
In 2010, there were 8.8 million tuberculosis (TB) cases worldwide, equalling a global incidence rate of 128
per 100 000 population. Between 9.6% and 11% of cases occurred in children aged ,15 years, with the
majority of cases seen in high TB burden countries [1]. The exact extent of childhood TB is unknown due to
the lack of a standard case definition, the wide spectrum of disease and inherent diagnostic difficulties [2].
Furthermore, until recently, the only cases reported with age disaggregation were smear-positive cases in
developing countries, while for smear-negative and extrapulmonary TB, age disaggregation was not
provided, so it is impossible to determine the real burden of childhood TB at the global level [3].
Many western European countries have registered an increasing incidence of TB amongst both adults and
children over the past two decades [4–7]. This is mainly driven by immigration from high-incidence areas.
In most countries of western Europe, childhood TB constitutes 4–7% of all TB cases and the highest
incidence rate is found among immigrants, with .40 cases per 100 000 immigrant children [4, 5].
Denmark has a low overall TB incidence rate of 6.8 per 100 000 with a total of 380 notified cases in 2011 [8].
However, the incidence rate of TB has fluctuated during the past decades. In 2000 there was a peak of 548
new cases resulting in an incidence rate of 10.3 per 100 000 population, due to an increasing number of
immigrants arriving from high-incidence countries [9]. Since 2002, a slight decrease in the number of
notified cases of TB has been observed paralleled with a decrease in immigration [10].
In the period between 1990 and 1999, a total of 349 children were notified for TB in Denmark and 78% of
these were immigrants. The TB incidence rate increased from 2.0 per 100 000 children in 1990 to 5.3 per
100 000 in 1999. The highest incidence rate was observed amongst immigrant children with an average of 46
annual cases per 100 000 in the study period [11].
Emphasis on improvement of early TB case detection is required as childhood TB is a key indicator for
recent transmission in society and because children are prone to severe manifestations of the disease and
increased mortality. The European Centre for Disease Prevention and Control (ECDC) now recommends
that each country should monitor trends in the ratio of the notification rate in children to that in adults as
an indicator of case-finding and effective treatment in the country [12].
The scope of this national study was to describe the recent TB epidemiology, clinical and microbiological
characteristics, and treatment outcomes in children aged ,15 years in Denmark over a 10-year period.
Material and methods
Study population
The Department of Infectious Disease Epidemiology at Statens Serum Institut (Copenhagen, Denmark),
which hosts the national TB surveillance system in Denmark, provided data on all notified TB cases aged
,15 years between January 2000 and December 2009. For analysis, we included data on demographics,
clinical manifestation, disease verification, source of infection, risk factors and treatment outcome. Non-
household exposure was defined as TB exposure that took place outside the house, mostly involving other
family members and adults at day care centres. All microbiological results from specimens from the notified
cases were retrieved from the International Reference Laboratory of Mycobacteriology (Statens Serum
Institut). Smears and culture were carried out on all samples, and a nucleic acid amplification (NAA) test
was performed if requested. Up to three initial samples per case obtained during the first 14 days of disease
investigation were included in the calculations. The Danish Data Protection Agency granted permission for
the study.
Subdivision of the study population
The study population was stratified according to immigrant status, which was defined as children born
abroad or those born in Denmark for whom one or both parents had been born abroad, including in
Greenland.
Statistics
General characteristics, stratified by immigrant status, are presented as percentage frequency, and
differences between variables of interest amongst immigrants and Danes were compared using the Chi-
squared or Fisher’s exact test. The results of the microbiological tests are also presented as percentage
frequency. Overall incidence rates per 100 000 children and incidence rate per 100 000 children subdivided
by age group (0–4, 5–9 and 10–14 years), sex and ethnicity were calculated using the mid-year estimates
from Statistics Denmark (www.dst.dk/en.aspx). In addition, the ratio of case notification in children to that
in adults was calculated as described in a recent ECDC publication [12]. The calculated incidence rates were
plotted against calendar years and the mean trend in the ratio of case notification rate in children to that in
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adults was calculated and plotted for the entire observation period. All statistical tests were two-sided and
the significance level was chosen as p,0.05.
Results
In the study period, 323 TB cases in children aged ,15 years were notified in Denmark. In total, 4224 TB
cases were notified during this period and, thus, childhood TB accounted for 7.6% of the total TB cases.
Demographic characteristics
Ethnicity was known in all but three cases. In total, 66 (20.4%) cases were Danes. 24 children originated
from other European countries, mostly from the Balkans. Six children were of Greenlandic origin. Children
of African origin comprised 57.9% (n5149) of the total number of TB cases in the immigrant group, with
the majority of children originating from Somalia (n5133). The second largest group of reported TB cases
were from Asia with a total of 65 TB cases. Among these, children from Pakistan and Afghanistan made up
the majority (n538) with a further 10 children of Middle Eastern origin. We had information on time of
entrance into Denmark for 136 of the immigrant children. The median time from entering Denmark to
diagnosis of TB in these cases was 3 years. 13 of the immigrant children were born in Denmark.
The general characteristics of childhood TB cases, stratified by immigrant status, are summarised in table 1.
The cases amongst Danish children were characterised by being young (0–4 years: 46.9%), predominantly
male (60.6%) and with a known non-household exposure to TB (43.9%). By contrast, the majority of TB
cases amongst immigrants were characterised by being older (10–14 years: 47.1%), predominantly female
(57.2%) and with unknown or other exposure to TB (42.8%).
Disease characteristics
Pulmonary TB was the commonest presentation of the disease in both Danish and immigrant children
(table 1). A higher proportion of immigrant children had lymphatic TB (13.6% versus 4.5%; p50.04)
compared with Danish children, and spinal, gastrointestinal and cutaneous TB were only observed among
immigrant children. However, tuberculous meningitis was more frequent in Danish children (7.3% versus
1.9%; p50.02).
The TB diagnosis was verified by a positive culture in 161 (49.8%) cases and there was no significant
difference in the proportion of culture verification between the two groups (p50.17). In addition, we found
an increase in positive culture with age (0–4 years: 43 out of 109, 5–9 years: 37 out of 80, 10–14 years: 81
out of 134; p,0.01). The diagnosis was more likely to be verified by tuberculin skin test (TST) in Danish
children (16.6% versus 8.2%; p50.04). A substantial number of cases were diagnosed by chest radiography
in both groups (table 1).
Incidence rate by age and sex
The incidence rates of childhood TB given by age and sex are shown in figure 1. The median age of all
children was 8 years. The highest incidence rate was 11.3 per 100 000 amongst females aged 10–14 years in
2001. The incidence in this group of children decreased in the following years reaching 2.35 per 100 000 in
2009 (fig. 1b).
Trends in the ratio of the notification rate
The 10-year trend in the ratio of TB case notifications in children to those in adults for all reported TB cases
is presented in figure 2. The ratio decreased over the study period, although an increase was observed in
2005 and 2007 (fig. 2a). The highest notification rate amongst children was 4.8 per 100 000 in 2001 and the
lowest was 1.9 per 100 000 in 2009. When we studied the trend in the ratio of the case notification rate in
Danish children to that in Danish adults, we observed a slightly increasing trend (fig. 2b). The notification
rate for Danish children and adults was 0.5 and 4.8 per 100 000 population, respectively, in 2000. In 2009,
the notification rate for Danish children had increased to 0.6 per 100 000, while the rate for Danish adults
had decreased to 2.6 per 100 000. In contrast, the ratio of the notification rates in immigrant children to
immigrant adults decreased over the same period (fig. 2c). The highest notification rate for immigrant
children was 94.1 per 100 000 immigrant children in 2001. The rate decreased to 35.1 per 100 000 in 2009.
The incidence for adult immigrants decreased during the observational period (97.2 to 44.9 per 100 000).
Bacterial results
Specimens were received for conventional mycobacterial diagnostics from 54 Danish children and 213
immigrant children. The results of microbiological tests from various specimens are shown in table 2. Of 90
sputum specimens, 28.8% were smear positive and 48.8% culture positive. 53 of the sputa were tested for
the presence of Mycobacterium tuberculosis DNA by NAA and 27 (50.9%) of these were positive. A total of
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237 gastric fluids were received and 12.2% and 42.6% were smear and culture positive, respectively.
M. tuberculosis was detected in 29% of gastric fluids tested by NAA. Acid-fast bacilli were detected by smear
in 17.1% of tissue biopsies and in 62.8% M. tuberculosis was cultured. The best performance of smear, NAA
and culture was found in pus material, where 47.6%, 75% and 90.4%, respectively, were positive (table 2).
The time to culture positivity ranged from 5 to 65 days (median 16 days).
Drug resistance
Drug susceptibility test results were available for 159 of the cases. Resistance to any drug was found in 18
children (resistance rate 11.3%). Mono-drug resistance to isoniazid was found in isolates from 13 children.
Ethambutol monoresistance was found in isolates from two children. Pyrazinamide mono-drug resistance
was found in an M. tuberculosis complex isolate from one child and in one Mycobacterium bovis isolate from
another child. Resistance to rifampicin, isoniazid and ethambutol (multidrug resistance) was found in one
isolate. This isolate was also resistant to rifabutin, but susceptible to amikacin, ofloxacin and capreomycin.
Extensively drug-resistant TB has not yet been reported in Denmark.
TABLE 1 Characteristics of tuberculosis cases in 323 children in Denmark
Danes Immigrants Chi-squared
Subjects 66 (20.4) 257 (79.6)
Sex
Male 40 (60.6) 110 (42.8) 0.0097
Female 26 (39.4) 147 (57.2)
Age years
0–4 31 (46.9) 78 (30.3) 0.0003
5–9 22 (33.3) 58 (22.6)
10–14 13 (19.7) 121 (47.1)
Risk factor
HIV/AIDS 1
Household exposure 26 (39.3) 95 (36.9) 0.7161
Non-household exposure 29 (43.9) 51 (19.8) 0.0048
Unknown/other 11 (16.6) 110 (42.8) 0.0046
Disease site
Pulmonary 54 (81.8) 189 (73.5)# 0.1647
Milliary 1 (1.5) 3 (1.2) 0.8197
Pleural 2 (3) 8 (3.1) 0.9725
Lymphatic 3 (4.5) 35 (13.6) 0.0413
Meningitis 5 (7.3) 5 (1.9) 0.0185
Spine 4 (1.5)
Bone
Gastrointestinal 7 (2.7)
Genito-urinary
Disseminated
Cutaneous 4 (1.5)
Others 1 (1.5) 2 (0.7)
Disease verification
Culture positive 28 (42.4) 133 (51.7) 0.1765
Smear positive 1 (1.5) 1 (0.4)
NAA positive 3 (4.5)
Clinical symptoms 3 (4.5) 4 (1.5) 0.1369
TST 11 (16.6) 20 (8.0) 0.0393
IGRA 1 (0.4)
Chest radiography 20 (30.3) 89 (34.6) 0.5072
Histology 7 (2.7)
None available 2 (0.7)
Data are presented as n (%), unless otherwise stated. NAA: nucleic acid amplification; TST: tuberculin skin
test; IGRA: interferon-c release assay. #: 17 immigrant children with pulmonary tuberculosis were also
registered with extrapulmonary localisation (lymph nodes (n58), gastrointestinal (n53), spine (n52), pleural
(n51), meningitis (n51), genitourinary (n51) and skin (n51)).
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Recurrence
In total, three cases were registered with a recurrence during the study period. All were immigrant children
and two of the cases had culture-verified TB. A patient was treated for TB spondylitis in 2001 and
pulmonary TB in 2007, and drug-susceptible strains were cultured in both occurrences. Another patient was
treated for drug-susceptible pulmonary TB in 2001 and 2005. The last case was treated for culture-negative
pulmonary TB verified by chest radiography in 2006 and culture-negative lymphatic TB in 2007. The
diagnosis was verified by a positive NAA test for M. tuberculosis in pus from cervical lymphadenitis.
Treatment outcome
Treatment outcome for both pulmonary and extrapulmonary TB has been reported by physicians since
2000, but is not mandatory in Denmark. As the results from the year 2000 were highly incomplete they were
excluded from analyses. In 226 (79.1%) of the cases the outcome was ‘‘treatment completed’’ and the
outcome ‘‘cured’’ was reported in 42 (14.7%) cases, yielding an overall treatment success for the years 2001
to 2009 at 93.8%. One child (,1%) died (fig. 3).
Discussion
The epidemiology of TB in Denmark has changed over the past decade. Restrictions in the Danish
immigration laws in the year 2000 resulted in a parallel decrease in immigration from high-incidence
countries and a decline in the overall TB incidence rate from 10.3 to 6.0 per 100 000 [9, 10]. In 2008, the
ECDC introduced the Framework Action Plan to Fight TB in the European Union (EU) and in 2010 the
supporting monitoring framework was published [12, 13]. Four epidemiological indicators were proposed
for monitoring and evaluating the quality of TB control. One of the indicators is childhood TB and the
ECDC target is defined as a mean decline in the 10-year trend in the ratio of notification rates in children to
that in adults. This trend reflects the change in the level of recent transmission and treatment efficiency in
the country. We observed an overall decreasing trend in this ratio between 2000 and 2009, although
fluctuations were seen. Interestingly, we found the opposite tendency when calculating this trend for Danish
childhood cases versus Danish adult cases alone. The observed slightly increasing trend can be explained by
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FIGURE 1 Incidence of childhood tuberculosis in a) males and b) females by age in Denmark between 2000 and 2009.
TUBERCULOSIS | C.I. HATLEBERG ET AL.
DOI: 10.1183/09031936.00059913 867
delays in case-finding among adult Danes. Although caution should be taken due to the low number of
cases, this finding supports other observations that draw attention to the need for improved TB control
among Danes; during the study period, the percentage of smear-positive adult pulmonary TB remained
high at 60–70% [14] and recently, KAMPER-JøRGENSEN et al. [15] have shown a high level of recent
transmission, with a cluster frequency of 78% in a genotype epidemiology study. In particular, the outbreak
strain Cluster 2 is found among young to middle-aged males living under difficult social conditions in the
Danish capital Copenhagen, where the majority of cases were reported.
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FIGURE 2 Trends in the ratio of notification rates in a) children to adults, b) Danish children to Danish adults and c) immigrant children to immigrant adults,
between 2000 and 2009 in Denmark.
TABLE 2 Yield of Mycobacterium tuberculosis in smear, nucleic acid amplification (NAA) test and culture using various
specimens in all notified cases for whom samples were obtained
Type of specimen Specimens n Smear positive for AFB Positive by NAA test for
M. tuberculosis n/N#(%)
Culture positive for
M. tuberculosis
Sputum 90 26 (28.8) 27/53 (50.9) 44 (48.8)
BAL 3 1/3 (33.3) 3 (100)
Tracheal aspirates 33 3 (9) 3/19 (15.7) 6 (18.1)
Gastric fluid 237 29 (12.2) 45/155 (29) 101 (42.6)
Tissue biopsy 35 6 (17.1) 10/27 (37) 22 (62.8)
Pleura fluid 10 2/7 (28.5) 3 (30)
Cerebrospinal fluid 16 3/11 (27.2) 7 (43.7)
Pus 21 10 (47.6) 9/12 (75) 19 (90.4)
Stool 4 2 (50)
Data are presented as n (%), unless otherwise stated. AFB: Acid-fast bacilli; BAL: bronchoalveolar lavage. #: N5number of NAA tests performed at
clinician’s request.
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We found that the proportion of childhood TB remained high and accounted for 7.6% of the total TB
burden in the observational period. This is comparable to the 8% observed in the previous decade [11]. This
percentage stands at 4.3% in all EU/European Economic Area (EEA) countries [7]. As reported by a
previous survey [11], children of foreign origin account for 80% of all childhood TB cases in Denmark. This
is much higher than reported in the EU/EEA as a whole (29.2%) [7]. In line with previous data from low-
incidence settings [4–6, 16], this is an extremely high incidence rate for foreign-born children considering
that most incident cases are found several or even many years after arrival in Denmark [17]. This is
especially true for Somali children.
A recent study describing paediatric TB (aged ,18 years) in Israel from 1999 to 2010 reported declining
case rates during the study period [18]. Similar to Denmark, Israel is also a country with a low overall
incidence of TB. The main findings of the Israeli study were a high proportion of childhood TB (8.4%) and
a very high incidence amongst children whose parents were born in Ethiopia (7.5 per 100 000) and in the
children of migrant workers (50–100 per 100 000), in line with our study. The majority of these children,
who migrated to Israel, developed TB in the first year after arrival compared with a median period of
3 years after arrival in our study. However, there are important differences between Israel and Denmark
with respect to TB case-finding. In Israel, initial screening for TB is routinely offered to all immigrants,
whereas in Denmark TB screening is only offered to refugees and asylum seekers as they enter Denmark.
The high case rates in immigrants originating from high TB incidence regions stresses the need for
continuous attention towards this group and highlights the importance of early TB screening to diagnose all
cases with latent and active disease, so that relevant treatment can be started as soon as possible.
The sex distribution of TB is well described amongst adults, with a male to female ratio of about two to one,
which is found both in low- and high-incidence countries [19, 20]. However, the ratio is not well described
for children. We found significant differences between Danish and immigrant children with respect to sex
distribution. We do not have any explanation for this observation.
In general, children are at significantly higher risk of developing active disease after primary infection and
age is one of the key parameters in this process. Infants and children aged ,2 years were reported to be
more vulnerable to developing the disseminated disease [21, 22]. Native Danish children aged 0–4 years
were at significantly more risk of having TB than immigrant children in this age group. This feature was also
observed in the EU/EEA region [7]. Conversely, for children aged 10–14 years, the immigrant group had a
much higher risk of disease development than the Danish group.
The majority of the Danish children in this study had known contact with a TB patient. This is an important
parameter to disclose since contact tracing with isoniazid preventive treatment may not have been optimal,
as such measures would have lowered the risk of subsequent disease [23]. Furthermore, delays in diagnosing
adult TB may have the result that children have developed the disease at the time of screening. Among
immigrant children, TB exposure was unknown or reported to be ‘‘other’’ in 43% of the TB cases, which
could reflect exposure before entering Denmark.
The majority of children in both groups suffered from pulmonary TB. Tuberculous meningitis was
significantly more common amongst Danish children, which is explained by the lower age of TB cases in
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FIGURE 3 Treatment outcomes for
both pulmonary and extrapulmonary
notified childhood tuberculosis
between 2001 and 2009 in Denmark.
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this group. Lymphatic TB was the second most common manifestation and was primarily reported amongst
immigrant children. This is comparable to the national TB profile, where almost 90% of lymphatic TB
occurred amongst immigrant patients [14, 24].
Ensuring a microbiologically verified diagnosis is still a major challenge in paediatric cases. Due to
difficulties and inconvenience in sample collections, the percentage of specimen collection is usually low in
the paediatric population. However, clinical specimens for microbiological tests were received in 82% of the
current study population. Even higher percentages would be beneficial, but are probably difficult to achieve.
Both acid-fast bacilli smear and culture were very insensitive, and even the performance of NAA was very
low. The percentage of culture-confirmed TB was as low as 50% in our paediatric population. However, this
is comparable with previous reports from western Europe [4, 6, 7]. In 2009, only 19.2% of paediatric TB
cases were culture-confirmed in the EU/EEA, where optimal microbiological facilities are established [7].
The reason for the low sensitivity of bacteriological tests is primarily the paucibacillary nature of the disease
in children. Submitting good-quality specimens is still important and encouraged in the new EU standards
for TB care [25, 26].
The proportion of TB diagnoses based on a positive TST was significantly higher amongst Danish children
who were not part of the bacille Calmette–Gue´rin vaccination programme terminated in 1984 and
interpretation of a positive TST is probably easier in combination with clinical findings in the low-incidence
population. This study is based on the epidemiological and microbiological data, which do not fully reflect
the true and comprehensive process of assembling the diagnosis. Recently, published data based on
information from case files found, that a combination of a positive TST, an abnormal chest radiograph and
a history of exposure led to treatment commencement in 76% of cases [27]. There is a need for an improved
diagnostic tool. The new lipoarabinomannan TB urine test may play an important role in the future. The
test has shown promising results in diagnosing TB in severely immunocompromised HIV patients [28]. It
could be of significant interest to investigate the performance of this test in a paediatric population.
Drug-resistant TB is not a major problem in Denmark, but the occurrence of resistance to first-line drugs in
11% of culture positive cases warrants close monitoring. Multidrug-resistant TB is rarely seen and
extensively drug-resistant TB has not yet been reported [29, 30].
The overall treatment success of 94% in this study exceeded the target of 85% in the EU area [12].
Fortunately, childhood TB mortality was low, as only one child died. In order to improve surveillance of
treatment outcome, we recommend mandatory reporting of treatment outcome, possibly combined with an
electronic surveillance system.
Conclusion
Improvement in early case detection of adult TB cases is necessary to reduce transmission in the society,
which in turn will ultimately reduce the number of childhood TB cases. Furthermore, an increased focus on
contact tracing and preventive treatment is warranted. Finally, focus on groups at high risk for disease
development may prove fruitful.
Paediatric TB represents failure to control transmission in the society and contributes significantly to the
burden of disease as a reservoir; hence, continuous national and international commitment is necessary to
ensure the highest standards of TB care and control in this highly vulnerable population [31].
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